整合临床背景与超声特征判定甲状腺活检适宜性:一项回顾性研究
该研究在美国单中心回顾2016至2023年成人首次甲状腺细针穿刺活检,采用整合超声特征与临床因素的阶梯框架评估适宜性。481例活检中80.7%为可能适宜,7%因临床因素从可能不适宜上调,10%因预期寿命有限从可能适宜下调,仅0.8%为极度不适宜。结论强调结合超声与临床背景可优化活检决策并提升以患者为中心的照护。
要点
- 多数甲状腺活检(80.7%)按ACR TI-RADS标准为可能适宜。
- 临床因素可使7%的可能不适宜活检上调为可能适宜。
- 预期寿命有限可使10%的可能适宜活检下调为不适宜。
核心结论
- 整合超声特征与临床背景有助于指导甲状腺活检决策并提升以患者为中心的照护。
研究设计与样本
- 共评估899例患者,441例符合纳入标准,共进行481次甲状腺活检。
主要发现
- 481次活检中388次(80.7%)基于ACR TI-RADS标准归类为可能适宜(L-APP)。
- 34次(7%)因甲状腺癌风险特征、合并症、症状或患者偏好从可能不适宜(L-INAP)重新归类为L-APP。
- 50次(10%)因预期寿命有限(如化疗、终末期疾病)从L-APP重新归类为可能或极度不适宜(EXT-INAP)。
- 极度不适宜(EXT-INAP)活检仅占0.8%(4/481)。
临床怎么用
- 甲状腺活检决策应结合超声特征与患者临床背景(如合并症、预期寿命、患者偏好)综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Thyroid nodules are common in clinical practice, and inappropriate selection of patients for thyroid biopsy can contribute to thyroid cancer overdiagnosis or delayed diagnosis. OBJECTIVE: This work aimed to evaluate the frequency of inappropriate thyroid biopsies in practice, following a framework that integrates thyroid nodule ultrasound (US) features and patient-specific clinical factors. METHODS: This cross-sectional study was conducted at a single academic center in the United States. Participants included adult patients who underwent their first thyroid fine-needle aspiration (FNA) biopsy between January 1, 2016, and December 31, 2023, at the University of Florida. Data collection included thyroid US characteristics, clinical factors (eg, comorbidities, patient preferences), and context for biopsy decision-making. Main outcome measures included the appropriateness of thyroid biopsy assessed using a tiered framework incorporating US features and additional clinical factors. RESULTS: A total of 899 patients were evaluated, with 441 meeting the inclusion criteria and undergoing 481 thyroid biopsies. Of these, 388 of 481 (80.7%) were classified as likely appropriate (L-APP) based on the American College of Radiology Thyroid Imaging Reporting and Data System criteria. In 34 of 481 (7%) of cases, clinical factors such as thyroid cancer risk features, comorbidities, symptoms, or patient preferences led to reclassification from likely inappropriate (L-INAP) to L-APP. In 50 of 481 (10%) of cases, limited life expectancy (eg, chemotherapy, end-stage disease) led to reclassification from L-APP to possibly or extremely inappropriate (EXT-INAP). EXT-INAP biopsies occurred in only 0.8% (4/481) of cases. CONCLUSION: This study underscores the value of integrating US findings with clinical context to guide thyroid biopsy decisions and enhance patient-centered care.
引用
- Habib S, Perez Rodriguez Garcia G, Zhang Z, et al. Determining Thyroid Biopsy Appropriateness: A Retrospective Study Integrating Clinical Context and Ultrasound Features. J Clin Endocrinol Metab. 2026. PMID: 41133765. doi:10.1210/clinem/dgaf577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。